MedTech Outlook | Business and Technology magazine for medical device industry

Sharon Wrona DNP, RN-BC, PNP, PMHS, AP-PMN, FAAN, Director Comprehensive Pain & Palliative Care Services, Nationwide Children's Hospital

Mark Wehde Chair, Mayo Clinic Engineering

David Pudwill, Senior Director, Regulatory Affairs, ConvaTec

Anand Murthi, Chief, Shoulder and Elbow Surgery, MedStar Union Memorial Hospital

Greg Maeder, Medical Director, Goodness Health Group

Roger Smith, PhD, CTO, Florida Hospital Nicholson Center

Mina Jacob, Interventional Cardiologist, Infirmary Health

Vincent J Pompili MD. FACC, FSCAI, SVP, Novant Health

James G Guerrini, Medical Director Urgent Care, Wake Forest Baptist Health

Partho Sengupta, Chief, Division of Cardiology, WVU Medicine

There are currently two most important issues with respect to cardiovascular diseases, which need to be largely addressed.

Chuck Hughes, Medical Device Reprocessing Consultant, HIGHPOWER Validation Testing & Lab Services

David Anderson, Commercial Affairs Lead, SITES Medical

Why hasn't anyone done this yet? To begin with, many of the contemporary porous ingrowth technologies are expensive to manufacture.

Janna Parks, Director Operations Quality, Abbott [NYSE:ABT]

Dr. James Suliburk, Associate Professor of Surgery and Chief of Endocrine Surgery, Baylor College of Medicine

Sebastian G. de la Fuente, Director Hepato-Pancreato-Biliary fellowship, Florida Hospital

Leslie Clonch, CIO & VP, Texas Scottish Rite Hospital for Children

Sharon Wrona DNP, RN-BC, PNP, PMHS, AP-PMN, FAAN, Director Comprehensive Pain & Palliative Care Services, Nationwide Children's Hospital

Jonathan C. Levy, MD, Chief of Orthopedic Surgery, Holy Cross Hospital